本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CRISPR Therapeutics AG

51.72
-0.5400-1.03%
盤後51.800.0800+0.15%19:47 EDT
成交量:85.67萬
成交額:4,464.35萬
市值:50.01億
市盈率:-10.87
高:53.21
開:52.35
低:51.62
收:52.26
52周最高:78.48
52周最低:44.12
股本:9,669.26萬
流通股本:9,316.62萬
量比:0.69
換手率:0.92%
股息:- -
股息率:- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
淨資產收益率:-26.09%
總資產收益率:-14.20%
市淨率:2.86
市盈率(LYR):-7.99

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/11

重要事件披露

Form 8-K - Current report
2026/02/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

重要事件披露

Form 8-K - Current report
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities